4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-046263
Chief Accounting Officer sold 907 shares at $8.97 ($8,135)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-26 | Sale : show line 1 in the form | −907 | $8.97 | $8,135 | 1,925 | D |
| Open-market sales · 907 sh · avg $8.97 · $8,135 | ||||||
Loading xslF345X05/ownership.xml…